Albemarle (ALB) to Release Quarterly Earnings on Wednesday

Albemarle (NYSE:ALB) is expected to be announcing its Q3 2025 results after the market closes on Wednesday, November 5th. Analysts expect the company to announce earnings of ($0.97) per share and revenue of $1.2710 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, November 6, 2025 at 8:00 AM ET.

Albemarle Stock Performance

Albemarle stock opened at $96.45 on Tuesday. The stock has a market cap of $11.35 billion, a P/E ratio of -10.35 and a beta of 1.65. The company has a current ratio of 2.31, a quick ratio of 1.47 and a debt-to-equity ratio of 0.38. The stock has a 50 day moving average of $87.52 and a 200-day moving average of $73.41. Albemarle has a 52 week low of $49.43 and a 52 week high of $113.91.

Albemarle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Friday, December 12th will be given a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, December 12th. Albemarle’s dividend payout ratio is currently -17.38%.

Institutional Investors Weigh In On Albemarle

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. MML Investors Services LLC raised its stake in shares of Albemarle by 1.3% during the second quarter. MML Investors Services LLC now owns 16,991 shares of the specialty chemicals company’s stock valued at $1,065,000 after purchasing an additional 217 shares in the last quarter. Rakuten Securities Inc. raised its stake in shares of Albemarle by 57.7% during the second quarter. Rakuten Securities Inc. now owns 1,238 shares of the specialty chemicals company’s stock valued at $78,000 after purchasing an additional 453 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Albemarle by 536.7% during the second quarter. EverSource Wealth Advisors LLC now owns 573 shares of the specialty chemicals company’s stock valued at $36,000 after purchasing an additional 483 shares in the last quarter. IHT Wealth Management LLC raised its stake in shares of Albemarle by 3.4% during the second quarter. IHT Wealth Management LLC now owns 15,757 shares of the specialty chemicals company’s stock valued at $987,000 after purchasing an additional 515 shares in the last quarter. Finally, Advisory Services Network LLC raised its stake in shares of Albemarle by 9.1% during the second quarter. Advisory Services Network LLC now owns 7,142 shares of the specialty chemicals company’s stock valued at $485,000 after purchasing an additional 598 shares in the last quarter. 92.87% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on ALB shares. Rothschild Redb raised Albemarle to a “strong-buy” rating in a research report on Friday, October 24th. TD Cowen upped their price target on Albemarle from $70.00 to $85.00 and gave the company a “hold” rating in a research report on Thursday, October 9th. Dbs Bank upped their price target on Albemarle from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Friday, October 24th. Cowen reissued a “hold” rating on shares of Albemarle in a research report on Thursday, October 9th. Finally, Bank of America reiterated a “neutral” rating and set a $100.00 price target (up from $95.00) on shares of Albemarle in a research report on Tuesday, October 14th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, fourteen have given a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $96.13.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.